| Identification | Back Directory | [Name]
[1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(1-piperazinylmethyl)- | [CAS]
1403255-41-3 | [Synonyms]
EZH2-IN-13
[1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(1-piperazinylmethyl)- | [Molecular Formula]
C34H45N5O3 | [MOL File]
1403255-41-3.mol | [Molecular Weight]
571.75 |
| Chemical Properties | Back Directory | [Boiling point ]
760.6±60.0 °C(Predicted) | [density ]
1.149±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
11.92±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Description]
EZH2-IN-13 is a potent EZH2 inhibitor, for details please refer to compound 73 in patent WO2017139404. EZH2-IN-13 can be used to study cancers or precancerous lesions associated with EZH2 activity[1]. | [Uses]
EZH2-IN-13 is a potent EZH2 inhibitor, for details please refer to compound 73 in patent WO2017139404. EZH2-IN-13 can be used to study cancers or precancerous lesions associated with EZH2 activity[1]. | [storage]
Store at -20°C | [References]
[1] Jesse Smith, et al. Methods of treating cancer. WO2017139404. |
|
|